WEPON, a pharmaceutical enterprise to speak for China’s top technology drugs

Pioneer for innovation, care for life

Specialized in the R&D, manufacturing and sales of TCM extracts, chemically synthesized APIs, pharmaceutical intermediates and other products.

社会责任

About Us

In the next three years, WEPON is planning to invest RMB 1 billion to build a manufacturing base for generic drug R&D, API and products.
More
ball

R&D News

2021-08-11

Tang Xican, academician of the Chinese Academy of Engineering, visited Wanbangde Pharmaceutical

On October 21, Tang Xican, academician of the Chinese Academy of Engineering, visited Wanbangde Pharmaceutical to inspect and guide the work and discuss and exchange, accompanied by relevant personnel of Wenling Association for Science and Technology.
2021-08-11

Tang Xican, academician of the Chinese Academy of Engineering, visited Wanbangde Pharmaceutical

On October 21, Tang Xican, academician of the Chinese Academy of Engineering, visited Wanbangde Pharmaceutical to inspect and guide the work and discuss and exchange, accompanied by relevant personnel of Wenling Association for Science and Technology.
2019-11-06

Wanbond Pharmaceutical successfully held the 6th Taizhou Drug Quality Research Salon

On November 5, the sixth Taizhou Pharmaceutical Quality Research Salon, hosted by Taizhou Pharmaceutical Society and Pharmaceutical Quality Research Professional Committee and undertaken by Wanbangde Pharmaceutical Group Co., Ltd. was successfully held in Wenling International Hotel.

合作伙伴

©2021 API Division of Wanbangde Pharmaceutical Group Co., Ltd. All Rights Reserved.    浙ICP备12004244号